Items where authors include "Luqmani, R."

Article

Manning, J.E., Harris, E., Mathieson, H. et al. (6 more authors) (2024) Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue. Journal of Autoimmunity, 147. 103260. ISSN 0896-8411

Zhao, S.S. orcid.org/0000-0002-3558-7353, Rogers, K., Kearsley-Fleet, L. orcid.org/0000-0003-0377-1575 et al. (195 more authors) (2024) Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology, 63 (3). pp. 648-656. ISSN 1462-0324

Borrego-Yaniz, G., Ortiz-Fernández, L., Madrid-Paredes, A. et al. (291 more authors) (2024) Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology, 6 (6). e374-e383. ISSN 2665-9913

Zhao, S.S. orcid.org/0000-0002-3558-7353, Rogers, K., Kearsley-Fleet, L. orcid.org/0000-0003-0377-1575 et al. (195 more authors) (2024) Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology, 63 (3). pp. 648-656. ISSN 1462-0324

Goodfellow, N., Morlet, J., Singh, S. et al. (7 more authors) (2017) Is vascular endothelial growth factor a useful biomarker in giant cell arteritis? RMD Open, 3 (1). e000353. ISSN 2056-5933

Luqmani, R., Lee, E., Singh, S. et al. (16 more authors) (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technology Assessment, 20 (90). ISSN 1366-5278

Javaid, M.K., Forestier-Zhang, L., Watts, L. et al. (15 more authors) (2016) The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases. Orphanet Journal of Rare Diseases, 11 (1). 150. ISSN 1750-1172

Latimer, N. R. orcid.org/0000-0001-5304-5585, Carroll, C., Wong, R. orcid.org/0000-0002-4536-4794 et al. (3 more authors) (2014) Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal. PharmacoEconomics, 32 (12). pp. 1171-1183. ISSN 1170-7690